Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Journal of Surgical Oncology

Volumn 105, Issue 3, 2012, Pages 293-296

  Wang, Lin Bo ^a   Teng, Rong Yue ^a   Jiang, Zi Nong ^a   Hu, Wen Xian ^a   Dong, Min Jun ^a   Yuan, Xiao Ming ^a   Chen, Wen Jun ^a   Jin, Mei ^a   Shen, Jian Guo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

gastric cancer; neoadjuvant chemotherapy; tumor regression grade

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; OXALIPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH CANCER; THROMBOCYTE COUNT; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; SEX DISTRIBUTION; STOMACH NEOPLASMS;

EID: 84863014972     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22085     Document Type: Article

References (18)

1. Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
3. Carlomagno C, Pepe S, D'Armiento FP, et al.: Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer. Oncology 2010; 78: 369-375.
4. Langer R, Ott K, Feith M, et al.: Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas. Mod Pathol 2009; 22: 1555-1563.
5. Suárez J, Vera R, Balén E, et al.: Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 2008; 10: 563-568. (Pubitemid 351803062)
6. Giralt J, Eraso A, Armengol M, et al.: Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54: 1460-1465. (Pubitemid 35380048)
7. Smith FM, Reynolds JV, Kay EW, et al.: COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2006; 64: 466-472. (Pubitemid 43083434)
8. Mandard AM, Dalibard F, Mandard JC, et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-2686. (Pubitemid 24166250)
9. Beddy D, Hyland JM, Winter DC, et al.: A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008; 15: 3471-3477.
10. Wang LB, Shen JG, Xu CY, et al.: Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study. Hepatogastroenterology 2008; 55: 1895-1898.
11. Mallery S, DeCamp M, Bueno R, et al.: Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Cancer 1999; 86: 764-769. (Pubitemid 29399914)
12. Brown WA, Thomas J, Gotley D, et al.: Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy. Br J Surg 2004; 91: 199-204. (Pubitemid 38233965)
13. Biondo S, Navarro M, Marti-Rague J, et al.: Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis 2005; 7: 472-479. (Pubitemid 41223142)
14. Yonemori K, Shimada Y, Goto A, et al.: Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy. Gastric Cancer 2004; 7: 204-210.
15. Ajani JA, Mansfield PF, Crane CH, et al.: Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 2005; 23: 1237-1244. (Pubitemid 46202281)
16. Janjan NA, Khoo VS, Abbruzzese J, et al.: Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-1038. (Pubitemid 29342903)
17. Willett CG, Warland G, Coen J, et al.: Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 57-61.
18. Timovska YO, Pivnyuk VM, Oliynichenko GP, et al.: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer. Exp Oncol 2009; 31: 231-236.